These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Role of poly(ADP-ribose) polymerases-1-mediated blockade of autophagy in ischemia/reperfusion injury of rat cardiomyocytes].
    Author: Zhao W, Wang Y, Wei G, Xu S.
    Journal: Nan Fang Yi Ke Da Xue Xue Bao; 2018 Jul 30; 38(8):975-979. PubMed ID: 30187876.
    Abstract:
    OBJECTIVE: To investigate the role of poly(ADP-ribose) polymerases-1 (PARP-1)-mediated blockade of autophagic flow in myocardial ischemia-reperfusion injury. METHODS: H9c2 cells, a rat cardiac myocyte line, were divided into control group, hypoxia/ reoxygenation model group (H/R group), PARP-1 inhibitor (PJ34) group, and PJ34 + H/R group. The total protein was extracted from the cells in each group to detect the expressions of pADPr, Bax, the DNA damage marker protein p-YH2ax, and autophagic flow-associated proteins LC3BⅡ/LC3Ⅰ, Beclin-1, and P62 using Western blotting. RESULTS: Compared with the control cells, the cells with H/R exhibited significantly increased expressions of pADPr, Bax and p-YH2ax (P < 0.05). The expressions of LC3B Ⅱ, beclin-1 and p62 were also increased significantly in the cells with H/R (P < 0.05), indicating the block of the autophagic flow. The application of PARP-1 inhibitor PJ34 in the cells with H/R significantly inhibited the expressions of pADPr (P < 0.05) and Bax (P < 0.01), and alleviated DNA damage in the cells. PJ34 treatment did not cause significant changes in the expressions of LC3B Ⅱ and beclin-1 but significantly decreased the expression of p62 (P < 0.05) in the cells with H/R. CONCLUSIONS: Block of autophagic flow mediated by PARP-1 activation plays a role in myocardial ischemiareperfusion injury, and inhibition of PARP-1 activity can reverse autophagic flow block to reduce the injury. 目的: 探讨PARP-1介导的自噬流受阻在大鼠心肌缺血再灌注损伤（MIRI）中的作用。 方法: 采用大鼠心肌细胞H9c2制备缺血再灌注细胞模型。实验分为对照组、缺氧/复氧处理模型组、PARP-1抑制剂组、PARP-1抑制剂+模型组（PJ34+H/R组）。取各组处理后的6孔板H9c2细胞提取总蛋白后Western blot分别检测PARP-1活性蛋白pADPr，凋亡相关蛋白Bax，细胞DNA损伤标记蛋白p-γH2ax的表达，细胞自噬流相关蛋白：LC3BⅡ/LC3Ⅰ、Beclin-1、P62的表达量。通过GraphPad Prism 6统计软件对数据进行分析，比较各组间差异。 结果: 与对照组比较，MIRI模型组PARP-1活性标记物pADPr表达更高表示PARP-1激活增多，细胞凋亡损伤增加，DNA损伤（p-γH2ax）也增多（P < 0.05）。LC3B Ⅱ、beclin-1表达增高，同时p62表达也增高（P < 0.05），表示自噬流受阻。与模型组比较，加入PARP-1抑制剂后（H/R+PJ34组）可明显抑制心肌细胞内PARP-1活性（pADPr），细胞凋亡减少，细胞DNA损伤也减轻（P < 0.05）；自噬相关蛋白LC3B Ⅱ、beclin-1表达无明显变化，而p62表达降低（P < 0.05），表明自噬流受阻情况得到缓解（P < 0.05）。 结论: PARP-1激活介导的自噬流受阻在大鼠MIRI中发挥着作用，通过抑制PARP-1活性后可明显逆转自噬流受阻情况，减轻MIRI。
    [Abstract] [Full Text] [Related] [New Search]